๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Rituximab as a first-line agent for the treatment of dermatomyositis

โœ Scribed by Haroon, Muhammad; Devlin, Joe

Book ID
113028757
Publisher
Springer
Year
2010
Tongue
English
Weight
107 KB
Volume
32
Category
Article
ISSN
0172-8172

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Rituximab for the treatment of juvenile
Rituximab for the treatment of juvenile dermatomyositis: A report of four pediatric patients
โœ Megan A. Cooper; Donna L. Willingham; Diane E. Brown; Anthony R. French; Fei F. ๐Ÿ“‚ Article ๐Ÿ“… 2007 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 60 KB ๐Ÿ‘ 1 views

## Abstract ## Objective Juvenile dermatomyositis (DM) is a chronic inflammatory myopathy of childhood primarily affecting the muscles and skin. Treatment for juvenile DM is often difficult, and conventional therapies include corticosteroids and other immune suppressants. We reviewed the records o